Related references
Note: Only part of the references are listed.A Natural Polyphenol Exerts Antitumor Activity and Circumvents Anti-PD-1 Resistance through Effects on the Gut Microbiota
Meriem Messaoudene et al.
CANCER DISCOVERY (2022)
Ginseng polysaccharides alter the gut microbiota and kynurenine/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1/programmed cell death ligand 1 (anti-PD-1/PD-L1) immunotherapy
Jumin Huang et al.
GUT (2022)
Lacticaseibacillus paracasei sh2020 induced antitumor immunity and synergized with anti-programmed cell death 1 to reduce tumor burden in mice
Shi-Long Zhang et al.
GUT MICROBES (2022)
Therapeutic Opportunities for Intestinal Angioectasia- Targeting PPARγ and Oxidative Stress
Mayur Sarangdhar et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2021)
Tripartite relationship between gut microbiota, intestinal mucus and dietary fibers: towards preventive strategies against enteric infections
Thomas Sauvaitre et al.
FEMS MICROBIOLOGY REVIEWS (2021)
Epithelial TLR4 Signaling Activates DUOX2 to Induce Microbiota-Driven Tumorigenesis
Juan F. Burgueno et al.
GASTROENTEROLOGY (2021)
Cryptotanshinone alleviates chemotherapy-induced colitis in mice with colon cancer via regulating fecal-bacteria-related lipid metabolism
Wang Lin et al.
PHARMACOLOGICAL RESEARCH (2021)
Mice with dysfunctional TGF-β signaling develop altered intestinal microbiome and colorectal cancer resistant to 5FU
Zhanhuai Wang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2021)
Cancer and the Microbiome-Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy
Vyara Matson et al.
GASTROENTEROLOGY (2021)
5-Aminosalicylic Acid Ameliorates Colitis and Checks Dysbiotic Escherichia coli Expansion by Activating PPAR-gamma Signaling in the Intestinal Epithelium
Stephanie A. Cevallos et al.
MBIO (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Current advancements and future perspectives of immunotherapy in colorectal cancer research
Chandra Kishore et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2021)
Intestinal Microbiota as a Contributor to Chronic Inflammation and Its Potential Modifications
Marta Potrykus et al.
NUTRIENTS (2021)
Dietary Rice Bran-Modified Human Gut Microbial Consortia Confers Protection against Colon Carcinogenesis Following Fecal Transfaunation
Kristopher D. Parker et al.
BIOMEDICINES (2021)
Microbiota regulate innate immune signaling and protective immunity against cancer
Changsheng Xing et al.
CELL HOST & MICROBE (2021)
Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8+ T cell immunity
Yao He et al.
CELL METABOLISM (2021)
Immune Evaluation of Recombinant Lactobacillus plantarum With Surface Display of HA1-DCpep in Mice
Hui Niu et al.
FRONTIERS IN IMMUNOLOGY (2021)
Sanguisorbae Radix Suppresses Colorectal Tumor Growth Through PD-1/PD-L1 Blockade and Synergistic Effect With Pembrolizumab in a Humanized PD-L1-Expressing Colorectal Cancer Mouse Model
Eun-Ji Lee et al.
FRONTIERS IN IMMUNOLOGY (2021)
Macrophages play a role in inflammatory transformation of colorectal cancer
Lu Lu et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2021)
Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial
Thierry Andre et al.
LANCET ONCOLOGY (2021)
Total Flavonoids of Glycyrrhiza uralensis Alleviates Irinotecan-Induced Colitis via Modification of Gut Microbiota and Fecal Metabolism
Shi-Jun Yue et al.
FRONTIERS IN IMMUNOLOGY (2021)
Immune System, Microbiota, and Microbial Metabolites: The Unresolved Triad in Colorectal Cancer Microenvironment
Michelle Hanus et al.
FRONTIERS IN IMMUNOLOGY (2021)
Akebia saponin D ameliorates metabolic syndrome (MetS) via remodeling gut microbiota and attenuating intestinal barrier injury
Song Yang et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Oroxylin A maintains the colonic mucus barrier to reduce disease susceptibility by reconstituting a dietary fiber-deprived gut microbiota
Dongsheng Bai et al.
CANCER LETTERS (2021)
Ganoderma lucidum polysaccharide modulates gut microbiota and immune cell function to inhibit inflammation and tumorigenesis in colon
Cuiling Guo et al.
CARBOHYDRATE POLYMERS (2021)
The Role of Gut Microbiota in Overcoming Resistance to Checkpoint Inhibitors in Cancer Patients: Mechanisms and Challenges
Youssef Bouferraa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade
Miles C. Andrews et al.
NATURE MEDICINE (2021)
Albuca Bracteate Polysaccharides Synergistically Enhance the Anti-Tumor Efficacy of 5-Fluorouracil Against Colorectal Cancer by Modulating beta-Catenin Signaling and Intestinal Flora
Xinyu Yuan et al.
FRONTIERS IN PHARMACOLOGY (2021)
Generation of systemic antitumour immunity via the in situ modulation of the gut microbiome by an orally administered inulin gel
Kai Han et al.
NATURE BIOMEDICAL ENGINEERING (2021)
Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentation
Hanchen Xu et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
The inflammatory pathogenesis of colorectal cancer
Mark Schmitt et al.
NATURE REVIEWS IMMUNOLOGY (2021)
The outer membrane protein Amuc_1100 of Akkermansia muciniphila promotes intestinal 5-HT biosynthesis and extracellular availability through TLR2 signalling
Junchao Wang et al.
FOOD & FUNCTION (2021)
Pectin supplement significantly enhanced the anti-PD-1 efficacy in tumor-bearing mice humanized with gut microbiota from patients with colorectal cancer
Shi-Long Zhang et al.
THERANOSTICS (2021)
5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future
Sona Vodenkova et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Triggering apoptosis by oroxylin A through caspase-8 activation and p62/SQSTM1 proteolysis
Yue Zhao et al.
REDOX BIOLOGY (2020)
Cruel to Be Kind: Epithelial, Microbial, and Immune Cell Interactions in Gastrointestinal Cancers
Shabnam Shalapour et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)
Fusobacterium nucleatum in the Colorectum and Its Association with Cancer Risk and Survival: A Systematic Review and Meta-analysis
Christian Gethings-Behncke et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)
Colibactin-positive Escherichia coli induce a procarcinogenic immune environment leading to immunotherapy resistance in colorectal cancer
Amelie Lopes et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling
Yaoyao Shi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Exploring the effective materials of flavonoids-enriched extract from Scutellaria baicalensis roots based on the metabolic activation in influenza A virus induced acute lung injury
HaiJuan Zhi et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2020)
Berberine regulates fecal metabolites to ameliorate 5-fluorouracil induced intestinal mucositis through modulating gut microbiota
Haitao Chen et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Patchouli alcohol attenuates 5-fluorouracil-induced intestinal mucositis via TLR2/MyD88/NF-kB pathway and regulation of microbiota
Jiazhen Wu et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Andrographolide potentiates PD-1 blockade immunotherapy by inhibiting COX2-mediated PGE2 release
Wen Liu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Auxiliary antitumor effects of fungal proteins from Hericium erinaceus by target on the gut microbiota
Dongdong Wang et al.
JOURNAL OF FOOD SCIENCE (2020)
Lactobacillus species inhibitory effect on colorectal cancer progression through modulating the Wnt/β-catenin signaling pathway
Roya Ghanavati et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2020)
Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer
Maria Paula Roberti et al.
NATURE MEDICINE (2020)
Dihydrotanshinone attenuates chemotherapy-induced intestinal mucositis and alters fecal microbiota in mice
Wang Lin et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
5-Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes
Sabrina Blondy et al.
CANCER SCIENCE (2020)
YYFZBJS ameliorates colorectal cancer progression in ApcMin/+ mice by remodeling gut microbiota and inhibiting regulatory T-cell generation
Hua Sui et al.
CELL COMMUNICATION AND SIGNALING (2020)
Astragaloside IV Exerts Anti-tumor Effect on Murine Colorectal Cancer by Re-educating Tumor-Associated Macrophage
Feng Liu et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2020)
Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy
Lukas F. Mager et al.
SCIENCE (2020)
Host-microbiota maladaptation in colorectal cancer
Alina Janney et al.
NATURE (2020)
The Gut Microbiome Is Associated with Clinical Response to Anti-PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer
Zhi Peng et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Astragalin Attenuates Dextran Sulfate Sodium (DSS)-Induced Acute Experimental Colitis by Alleviating Gut Microbiota Dysbiosis and Inhibiting NF-κB Activation in Mice
Lei Peng et al.
FRONTIERS IN IMMUNOLOGY (2020)
Traditional Chinese medicine formulas, extracts, and compounds promote angiogenesis
Lan Bu et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
CircRNA_0000392 promotes colorectal cancer progression through the miR-193a-5p/PIK3R3/AKT axis
Hanchen Xu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer
T. Andre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
FAM3D is essential for colon homeostasis and host defense against inflammation associated carcinogenesis
Weiwei Liang et al.
NATURE COMMUNICATIONS (2020)
The Intestinal Microbiota and Colorectal Cancer
Yiwen Cheng et al.
FRONTIERS IN IMMUNOLOGY (2020)
Longitudinal Multi-omics Reveals Subset-Specific Mechanisms Underlying Irritable Bowel Syndrome (vol 182, pg 1460, 2020)
Ruben A. T. Mars et al.
CELL (2020)
Parthenolide ameliorates colon inflammation through regulating Treg/Th17 balance in a gut microbiota-dependent manner
Yao-Jiang Liu et al.
THERANOSTICS (2020)
Pancreatic Cancer, Gut Microbiota, and Therapeutic Efficacy
Xiang Zhang et al.
JOURNAL OF CANCER (2020)
Positive Role of Chinese Herbal Medicine in Cancer Immune Regulation
Sumei Wang et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2020)
Interbacterial mechanisms of colonization resistance and the strategies pathogens use to overcome them
Matthew T. Sorbara et al.
MUCOSAL IMMUNOLOGY (2019)
Impact of 5 fluorouracil chemotherapy on gut inflammation, functional parameters, and gut microbiota
A. T. Sougiannis et al.
BRAIN BEHAVIOR AND IMMUNITY (2019)
A defined commensal consortium elicits CD8 T cells and anti-cancer immunity
Takeshi Tanoue et al.
NATURE (2019)
A new genomic blueprint of the human gut microbiota
Alexandre Almeida et al.
NATURE (2019)
Colorectal cancer in inflammatory bowel disease: review of the evidence
D. S. Keller et al.
TECHNIQUES IN COLOPROCTOLOGY (2019)
Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities
Suhas Vasaikar et al.
CELL (2019)
The Diversity of Gut Microbiome is Associated With Favorable Responses to Anti-Programmed Death 1 Immunotherapy in Chinese Patients With NSCLC
Yueping Jin et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases
Jason Lloyd-Price et al.
NATURE (2019)
Gut microbiota, a new frontier to understand traditional Chinese medicines
Wuwen Feng et al.
PHARMACOLOGICAL RESEARCH (2019)
Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment
Ji Lv et al.
CELL DEATH & DISEASE (2019)
Parthenolide regulates oxidative stress-induced mitophagy and suppresses apoptosis through p53 signaling pathway in C2C12 myoblasts
Yinghui Ren et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Ameliorative effect of Atractylodes macrocephala essential oil combined with Panax ginseng total saponins on 5-fluorouracil induced diarrhea is associated with gut microbial modulation
Jing Wang et al.
JOURNAL OF ETHNOPHARMACOLOGY (2019)
Intervention with α-Ketoglutarate Ameliorates Colitis-Related Colorectal Carcinoma via Modulation of the Gut Microbiome
Si Li et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Intrinsic Resistance to Immune Checkpoint Blockade in a Mismatch Repair-Deficient Colorectal Cancer
Carino Gurjao et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with updates hepatocellular carcinoma
Yi Zheng et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms
Ibrahim Halil Sahin et al.
BRITISH JOURNAL OF CANCER (2019)
Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism
Fengjie Huang et al.
NATURE COMMUNICATIONS (2019)
A next generation probiotic, Akkermansia muciniphila
Qixiao Zhai et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2019)
Diadzein ameliorates 5-fluorouracil-induced intestinal mucositis by suppressing oxidative stress and inflammatory mediators in rodents
Ayesha Atiq et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Therapeutic effects of lentinan on inflammatory bowel disease and colitis-associated cancer
Yanrong Liu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer
Sheng Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
RNA-Seq profiling of circular RNAs in human colorectal Cancer liver metastasis and the potential biomarkers
Hanchen Xu et al.
MOLECULAR CANCER (2019)
Fecal Fusobacterium nucleatum for the diagnosis of colorectal tumor: A systematic review and meta-analysis
Xinyu Zhang et al.
CANCER MEDICINE (2019)
The intimate relationship between gut microbiota and cancer immunotherapy
Arielle Elkrief et al.
GUT MICROBES (2019)
A randomised trial of the effect of omega-3 polyunsaturated fatty acid supplements on the human intestinal microbiota
Henry Watson et al.
GUT (2018)
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
V. Gopalakrishnan et al.
SCIENCE (2018)
The Intestinal Microbiota in Colorectal Cancer
Herbert Tilg et al.
CANCER CELL (2018)
Bacteroides fragilis Toxin Coordinates a Pro-carcinogenic Inflammatory Cascade via Targeting of Colonic Epithelial Cells
Liam Chung et al.
CELL HOST & MICROBE (2018)
Gut microbiota modulate T cell trafficking into human colorectal cancer
Eleonora Cremonesi et al.
GUT (2018)
Gut microbiome modulates efficacy of immune checkpoint inhibitors
Ming Yi et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies
Laurence Zitvogel et al.
SCIENCE (2018)
Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease
Hai-Qin Ma et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2018)
Co-inhibition of BET proteins and NF-κB as a potential therapy for colorectal cancer through synergistic inhibiting MYC and FOXM1 expressions
Tingyu Wu et al.
CELL DEATH & DISEASE (2018)
Protective Effects of Salvianolic Acid A against Dextran Sodium Sulfate-Induced Acute Colitis in Rats
Kai Wang et al.
NUTRIENTS (2018)
Dietary butyrate glycerides modulate intestinal microbiota composition and serum metabolites in broilers
Xiaojian Yang et al.
SCIENTIFIC REPORTS (2018)
Fusobacterium nucleatum and colorectal cancer: A review
Fu-Mei Shang et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2018)
Specific members of the predominant gut microbiota predict pouchitis following colectomy and IPAA in UC
Kathleen Machiels et al.
GUT (2017)
Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer
Jun Yu et al.
GUT (2017)
The myeloid immune signature of enterotoxigenic Bacteroides fragilis-induced murine colon tumorigenesis
E. Thiele Orberg et al.
MUCOSAL IMMUNOLOGY (2017)
Peptostreptococcus anaerobius Induces Intracellular Cholesterol Biosynthesis in Colon Cells to Induce Proliferation and Causes Dysplasia in Mice
Ho Tsoi et al.
GASTROENTEROLOGY (2017)
A microbial signature for Crohn's disease
Victoria Pascal et al.
GUT (2017)
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
Michael J. Overman et al.
LANCET ONCOLOGY (2017)
Gut microbiota modulation of chemotherapy efficacy and toxicity
James L. Alexander et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Chlorogenic Acid Ameliorates Experimental Colitis by Promoting Growth of Akkermansia in Mice
Zhan Zhang et al.
NUTRIENTS (2017)
Volatile Oil from Amomi Fructus Attenuates 5-Fluorouracil-Induced Intestinal Mucositisd
Ting Zhang et al.
FRONTIERS IN PHARMACOLOGY (2017)
Ginsenosides Rb3 and Rd reduce polyps formation while reinstate the dysbiotic gut microbiota and the intestinal microenvironment in ApcMin/+ mice
Guoxin Huang et al.
SCIENTIFIC REPORTS (2017)
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
TaChung Yu et al.
CELL (2017)
WNT Signaling and Colorectal Cancer
Emma M. Schatoff et al.
CURRENT COLORECTAL CANCER REPORTS (2017)
The Characteristics and Function of Bacterial Lipopolysaccharides and Their Endotoxic Potential in Humans
Anne Gnauck et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2016)
Oroxyloside prevents dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB pathway through PPARγ activation
Xiaoping Wang et al.
BIOCHEMICAL PHARMACOLOGY (2016)
Does the intestinal microbial community of Korean Crohn's disease patients differ from that of western patients?
Chang Soo Eun et al.
BMC GASTROENTEROLOGY (2016)
The Human Intestinal Microbiome in Health and Disease
Susan V. Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Gut microbiota imbalance and colorectal cancer
Johan Gagniere et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Lipopolysaccharide increases the release of VEGF-C that enhances cell motility and promotes lymphangiogenesis and lymphatic metastasis through the TLR4-NF-κB/JNK pathways in colorectal cancer
Guangwei Zhu et al.
ONCOTARGET (2016)
Butyrate and bioactive proteolytic form of Wnt-5a regulate colonic epithelial proliferation and spatial development
Kazuhiko Uchiyama et al.
SCIENTIFIC REPORTS (2016)
Anti-biofilm Activities from Resveratrol against Fusobacterium nucleatum
Zhiyan He et al.
FRONTIERS IN MICROBIOLOGY (2016)
Nutrients, Foods, and Colorectal Cancer Prevention
Mingyang Song et al.
GASTROENTEROLOGY (2015)
The Role of Curcumin in Modulating Colonic Microbiota During Colitis and Colon Cancer Prevention
Rita-Marie T. McFadden et al.
INFLAMMATORY BOWEL DISEASES (2015)
Reshaping faecal gut microbiota composition by the intake of trans-resveratrol and quercetin in high-fat sucrose diet-fed rats
U. Eteberria et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2015)
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
Ayelet Sivan et al.
SCIENCE (2015)
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Marie Vetizou et al.
SCIENCE (2015)
Gut microbiome development along the colorectal adenoma-carcinoma sequence
Qiang Feng et al.
NATURE COMMUNICATIONS (2015)
Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment
Ya-Nan Yu et al.
ONCOTARGET (2015)
Stimulus-selective crosstalk via the NF-κB signaling system reinforces innate immune response to alleviate gut infection
Balaji Banoth et al.
ELIFE (2015)
Microbiota disbiosis is associated with colorectal cancer
Zhiguang Gao et al.
FRONTIERS IN MICROBIOLOGY (2015)
Nutritional Keys for intestinal Barrier Modulation
Stefania De Santis et al.
FRONTIERS IN IMMUNOLOGY (2015)
Fusobacterium nucleatum and T Cells in Colorectal Carcinoma
Kosuke Mima et al.
JAMA ONCOLOGY (2015)
In silico and Ex vivo approaches identify a role for toll-like receptor 4 in colorectal cancer
Daniel A. Sussman et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)
Oroxylin A Prevents Inflammation-Related Tumor Through Down-Regulation of Inflammatory Gene Expression by Inhibiting NF-κB Signaling
Jing Yao et al.
MOLECULAR CARCINOGENESIS (2014)
Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy
Ting-Ting Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Structure of the gut microbiome following colonization with human feces determines colonic tumor burden
Nielson T. Baxter et al.
MICROBIOME (2014)
Gut Microbiota Protects against Gastrointestinal Tumorigenesis Caused by Epithelial Injury
Yu Zhan et al.
CANCER RESEARCH (2013)
Interleukin-6 Is Required for Pancreatic Cancer Progression by Promoting MAPK Signaling Activation and Oxidative Stress Resistance
Yaqing Zhang et al.
CANCER RESEARCH (2013)
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
Aleksandar D. Kostic et al.
CELL HOST & MICROBE (2013)
Regulation of intestinal epithelial permeability by tight junctions
Takuya Suzuki
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome
Dan Knights et al.
GUT (2013)
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Nicholas Arpaia et al.
NATURE (2013)
Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens
Katharine M. Ng et al.
NATURE (2013)
TLR4 Activates the β-catenin Pathway to Cause Intestinal Neoplasia
Rebeca Santaolalla et al.
PLOS ONE (2013)
Commensal Akkermansia muciniphila Exacerbates Gut Inflammation in Salmonella Typhimurium-Infected Gnotobiotic Mice
Bhanu Priya Ganesh et al.
PLOS ONE (2013)
Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
Noriho Iida et al.
SCIENCE (2013)
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic Treg Cell Homeostasis
Patrick M. Smith et al.
SCIENCE (2013)
The Role of Intestinal Microflora in Anti-Inflammatory Effect of Baicalin in Mice
Myung-Ah Jung et al.
BIOMOLECULES & THERAPEUTICS (2012)
4′-Bromo-5,6,7-trimethoxyflavone represses lipopolysaccharide-induced iNOS and COX-2 expressions by suppressing the NF-κB signaling pathway in RAW 264.7 macrophages
Dong Han Kim et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Gut microbiota accelerate tumor growth via c-jun and STAT3 phosphorylation in APCMin/+ mice
Yinghui Li et al.
CARCINOGENESIS (2012)
Berberine inhibits the proliferation of colon cancer cells by inactivating Wnt/β-catenin signaling
Ke Wu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Pretreatment with the probiotic VSL#3 delays transition from inflammation to dysplasia in a rat model of colitis-associated cancer
Caroline B. Appleyard et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)
Commensal Bacteroides Species Induce Colitis in Host-Genotype-Specific Fashion in a Mouse Model of Inflammatory Bowel Disease
Seth M. Bloom et al.
CELL HOST & MICROBE (2011)
The role of bacteria and pattern-recognition receptors in Crohn's disease
Si Ming Man et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species
Koji Atarashi et al.
SCIENCE (2011)
Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme
Bret D. Wallace et al.
SCIENCE (2010)
Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria
Ivaylo I. Ivanov et al.
CELL (2009)
Innate Immune Signaling by Toll-like Receptor-4 (TLR4) Shapes the Inflammatory Microenvironment in Colitis-Associated Tumors
Masayuki Fukata et al.
INFLAMMATORY BOWEL DISEASES (2009)
Intestinal barrier function: Molecular regulation and disease pathogenesis
Katherine R. Groschwitz et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2009)
Developmental switch of intestinal antimicrobial peptide expression
Sandrine Menard et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Resveratrol (trans-3,5,4′-trihydroxystilbene) ameliorates experimental allergic encephalomyelitis, primarily via induction of apoptosis in T cells involving activation of aryl hydrocarbon receptor and estrogen receptor
Narendra P. Singh et al.
MOLECULAR PHARMACOLOGY (2007)
Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as immune adjuvant
K Kurosaka et al.
JOURNAL OF IMMUNOLOGY (2005)
IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer
FR Greten et al.
CELL (2004)
Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor γ (BPARγ) heterodimer:: A basis for new therapeutic strategies
P Desreumaux et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Share Paper
